Medicare Enrolled
Dr. Indermohan Luthra, M.D.
Neurology · Rancho Mirage, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Luthra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Luthra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Luthra
Dr. Indermohan Luthra is a neurology specialist in Rancho Mirage, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Luthra performed 1,220 Medicare services across 680 unique beneficiaries.
Between the years covered by Open Payments, Dr. Luthra received a total of $12,357 from 73 pharmaceutical and/or device companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Luthra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 28% volume in CA
$12,357 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,220
Medicare services
Top 28% in CA for neurology
680
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~64 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
806 | $97 | $185 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
174 | $141 | $275 |
| New patient office visit, complex (60-74 min) | 79 | $163 | $350 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
28 | $43 | $223 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
26 | $236 | $450 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
21 | $378 | $750 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $141 | $300 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
20 | $74 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
18 | $96 | $175 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
15 | $64 | $120 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
12 | $206 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,357
Total received (2018-2024)
Avg $1,765/year across 7 years
Top 21% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
470
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,968 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$389 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,795
2023
$1,754
2022
$1,314
2021
$2,897
2020
$597
2019
$2,500
2018
$1,499
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$228
ABBVIE INC.
$226
ARGENX US, INC.
$214
Amylyx Pharmaceuticals, Inc.
$141
Neurocrine Biosciences, Inc.
$140
Novo Nordisk Inc
$118
UCB, Inc.
$116
CATALYST PHARMACEUTICALS, INC.
$93
GE HEALTHCARE
$63
Lilly USA, LLC
$58
Grifols USA, LLC
$56
Takeda Pharmaceuticals U.S.A., Inc.
$56
Genentech USA, Inc.
$49
LivaNova USA, Inc.
$47
Eisai Inc.
$45
Neurelis, Inc.
$29
Alnylam Pharmaceuticals Inc.
$28
Octapharma USA, Inc.
$23
Alexion Pharmaceuticals, Inc.
$23
MITSUBISHI TANABE PHARMA AMERICA, INC.
$22
Biogen, Inc.
$21
Top 3 companies account for 37.2% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,380
LivaNova USA, Inc.
$720
UCB, Inc.
$677
Teva Pharmaceuticals USA, Inc.
$602
Medtronic USA, Inc.
$495
Eisai Inc.
$485
ABBVIE INC.
$461
Abbott Laboratories
$429
PFIZER INC.
$405
ARGENX US, INC.
$364
Alexion Pharmaceuticals, Inc.
$340
EMD Serono, Inc.
$323
GENZYME CORPORATION
$301
Lundbeck LLC
$256
EISAI INC.
$223
Novartis Pharmaceuticals Corporation
$219
Biohaven Pharmaceuticals, Inc.
$211
Grifols USA, LLC
$210
Shire North American Group Inc
$195
Adamas Pharmaceuticals, Inc.
$195
Janssen Pharmaceuticals, Inc
$187
AbbVie, Inc.
$183
Amylyx Pharmaceuticals, Inc.
$164
Neurocrine Biosciences, Inc.
$155
E.R. Squibb & Sons, L.L.C.
$151
BOSTON SCIENTIFIC CORPORATION
$147
Genentech USA, Inc.
$146
Amgen Inc.
$142
Allergan, Inc.
$140
AbbVie Inc.
$130
Akcea Therapeutics, Inc.
$127
Nevro Corp.
$125
Novo Nordisk Inc
$118
Medtronic, Inc.
$113
Lilly USA, LLC
$100
CATALYST PHARMACEUTICALS, INC.
$93
Seqirus USA Inc
$93
Allergan Inc.
$84
CSL Behring
$81
MDD US Operations, LLC
$79
Mallinckrodt Hospital Products Inc.
$76
Takeda Pharmaceuticals U.S.A., Inc.
$73
Neurelis, Inc.
$69
SK Life Science, Inc.
$68
Strongbridge US INC.
$67
US WorldMeds, LLC
$65
GE HEALTHCARE
$63
Mallinckrodt Enterprises LLC
$60
Terumo BCT, Inc.
$60
Biohaven Pharmaceutical Holding Company Ltd.
$55
Sobi, Inc
$53
Vanda Pharmaceuticals Inc.
$52
NOVARTIS PHARMACEUTICALS CORPORATION
$51
Otsuka America Pharmaceutical, Inc.
$42
Acorda Therapeutics, Inc
$42
Avanir Pharmaceuticals, Inc.
$40
Amneal Pharmaceuticals LLC
$39
HOSPIRA, INC.
$36
Xeris Pharmaceuticals, Inc.
$29
Alnylam Pharmaceuticals Inc.
$28
Horizon Therapeutics plc
$24
Catalyst Pharmaceuticals, Inc.
$24
Octapharma USA, Inc.
$23
TG THERAPEUTICS, INC.
$23
MITSUBISHI TANABE PHARMA AMERICA, INC.
$22
SANOFI-AVENTIS U.S. LLC
$22
ACADIA Pharmaceuticals Inc
$21
Bio Products Laboratory USA, Inc.
$21
Sunovion Pharmaceuticals Inc.
$16
Jazz Pharmaceuticals Inc.
$16
Mitsubishi Tanabe Pharma America, Inc.
$15
Celgene Corporation
$12
Travere Therapeutics, Inc.
$4
Top 3 companies account for 22.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AJOVY · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BOTOX · BRIUMVI · Briviact · COMIRNATY · Cholbam · DUOPA · Duopa · EMGALITY · FYCOMPA · Fluad · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gammaplex · Gamunex-C · HETLIOZ · HYQVIA · Hizentra · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · LEMTRADA · LUMIZYME · Leqembi · MAYZENT · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ocrevus · Omnia · PANZYGA · Ponvory · Proclaim Family of SCS IPGs · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RYTARY · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · Soliris · Spectra Optia · Superion · TECFIDERA · TEGSEDI · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vumerity · Wegovy · XYREM · Xadago · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
22
Per 100K population
0.9
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Luthra is a clinical cardiology specialist, with above-average Medicare volume (top 28% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Luthra experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Luthra performed 806 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Luthra receive payments from pharmaceutical companies?
Yes. Dr. Luthra received a total of $12,357 from 73 companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Luthra's costs compare to other neurologists in Rancho Mirage?
Dr. Luthra's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Luthra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Rancho Mirage
Browse neurologists in Rancho Mirage ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology